Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Kobayashi, Iwaya, Moriya, Yamasaki, Tsuda, Yamamoto, Matsubara: "A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer." in: BMC clinical pathology, Vol. 13, pp. 5, (2013) (PubMed).
Braun, Mietzsch, Seibold, Schneeweiss, Schirmacher, Chang-Claude, Peter Sinn, Aulmann: "Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 26, Issue 9, pp. 1161-71, (2013) (PubMed).
Jacquemier, Charafe-Jauffret, Monville, Esterni, Extra, Houvenaeghel, Xerri, Bertucci, Birnbaum: "Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer." in: Breast cancer research : BCR, Vol. 11, Issue 2, pp. R23, (2009) (PubMed).
Bretschneider, Brand, Miller, Lowery, Kerin, Gannon, Denger: "Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner." in: Cancer research, Vol. 68, Issue 1, pp. 106-14, (2008) (PubMed).